Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs
Clinical trial NCT04461925 · UNKNOWN
Trial details
- NCT number
- NCT04461925
- Sponsor
- Institute of Cell Therapy
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-02
- Primary completion
- 2021-05-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.